InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Jenkins John Kenneth. Director active across 1 company, notably Corbus Pharmaceuticals Holdings, Inc.. Cumulatively, 4 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €18k. History available since 30 May 2024. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Jenkins John Kenneth has filed 4 disclosures in total. In the 4 recent sampled disclosures, all relating to Corbus Pharmaceuticals Holdings, Inc. (XNAS) where he is a Director, the transactions are sales, with total sell volume of EUR 17986 and a date range from 2024-06-03 to 2026-06-11. The main filings include a sale of EUR 17986.17757896017 published on 2025-06-02.